Type 2 Diabetes Medicines Exporter India to USA | City Drug House
City Drug House is a trusted exporter of Sematrinity (semaglutide) 2.4 mg injection from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Sematrinity (semaglutide) 2.4 mg injection is a glucagon-like peptide-1 (GLP-1) receptor agonist, launched in India by Sun Pharma in March 2026 for chronic weight management. It mimics the natural GLP-1 hormone, aiding in appetite regulation, reduced food cravings, and slowed gastric emptying, which leads to significant weight loss and improved metabolic health.
Action Mechanism:
Appetite Regulation: Mimics natural GLP-1 to signal fullness to the brain and decrease hunger.
Gastric Slowing: Delays stomach emptying, prolonging the feeling of fullness.
Metabolic Improvement: Increases insulin release when blood sugar is high and reduces glucose production in the liver.
Dosage & Administration:
Dose: 2.4 mg (often delivered in a formulation such as (2.4mg/0.75 ml).Frequency: Once-weekly.
Route: Subcutaneous injection (under the skin) in the abdomen, thigh, or upper arm.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House is a trusted exporter of Sematrinity (semaglutide) 2.4 mg injection from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Sematrinity (semaglutide) 2.4 mg injection is a glucagon-like peptide-1 (GLP-1) receptor agonist, launched in India by Sun Pharma in March 2026 for chronic weight management. It mimics the natural GLP-1 hormone, aiding in appetite regulation, reduced food cravings, and slowed gastric emptying, which leads to significant weight loss and improved metabolic health.
Action Mechanism:
Appetite Regulation: Mimics natural GLP-1 to signal fullness to the brain and decrease hunger.
Gastric Slowing: Delays stomach emptying, prolonging the feeling of fullness.
Metabolic Improvement: Increases insulin release when blood sugar is high and reduces glucose production in the liver.
Dosage & Administration:
Dose: 2.4 mg (often delivered in a formulation such as (2.4mg/0.75 ml).Frequency: Once-weekly.
Route: Subcutaneous injection (under the skin) in the abdomen, thigh, or upper arm.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
